FDA Releases Recent Animal Drug Approvals and Safety-Related Labeling Changes
The FDA’s Center for Veterinary Medicine has updated its Recent Animal Drug Approvals page to reflect the February approval of Abbreviated New Animal Drug Application 200-742.
The FDA’s Center for Veterinary Medicine has also updated its Recent Animal Drug Safety-Related Labeling Changes page to reflect safety-related labeling changes for the following approved animal drugs:
Stelfonta (tigilanol tiglate injection), for dogs, NADA 141-541, January 13, 2025
Credelio Cat (lotilaner), NADA 141-528, January 13, 2025
Galliprant (grapiprant tablets), for dogs, NADA 141-455, December 3, 2024
BRAVECTO 1-MONTH (fluralaner) Chews for Dogs, NADA 141-532, November 25, 2024
Synotic (fluocinolone acetonide 0.01% and dimethyl sulfoxide 60%), NADA 045-512, November 25, 2024
Animal Drug Safety-Related Labeling Changes